Huge, bacteria-eating viruses could be a game-changer for antibiotics that currently struggle to fend off deadly infections.

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...

Integrating the nanoflowers into a wound dressing helps to fight harmful bacteria while keeping healthy human cells intact.

By combining MERFISH imaging with expansion microscopy, researchers have unlocked a new way to study bacteria at the ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...

The need for new fast classification methods has become increasingly important. When a patient arrives at a medical center ...

In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

When it comes to bacterial infections, bacterial meningitis may not be the most common one, but it is certainly among the most serious. "The most worrisome part of bacterial meningitis is the ...